JBIO
Jade Biosciences
JBIO
JBIO
58 hedge funds and large institutions have $386M invested in Jade Biosciences in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
21% less capital invested
Capital invested by funds: $488M → $386M (-$102M)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
58
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$2.85M | |
| 2 | +$2.16M | |
| 3 | +$1.36M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.02M |
| 5 |
BlackRock
New York
|
+$816K |
Top Sellers
| 1 | -$5.01M | |
| 2 | -$2.69M | |
| 3 | -$1.69M | |
| 4 |
HS
HighVista Strategies
Boston,
Massachusetts
|
-$717K |
| 5 |
FAM
Fred Alger Management
New York
|
-$450K |